Literature DB >> 15043421

Effects of natural flavones and flavonols on the kinase activity of Cdk5.

Gerald Zapata-Torres1, Felipe Opazo, Cristián Salgado, Juan Pablo Muñoz, Hans Krautwurst, Carolina Mascayano, Silvia Sepúlveda-Boza, Ricardo B Maccioni, Bruce K Cassels.   

Abstract

A number of natural and synthetic flavonoids have been assessed previously with regard to their effects on the activity of cyclin-dependent kinases (Cdk1 and -2) related to the inhibition of cell cycle progression. On the other hand, the Cdk5/p35 system is of major importance in neuronal migration phenomena and brain development, and its deregulation is implicated in neurodegenerative diseases, particularly Alzheimer's. Here we show that some natural flavonoids inhibit the activity of the Cdk5/p35 system in the micromolar range, while others are practically inactive. Ring B-unsubstituted and highly methoxylated flavones were inactive or gave irreproducible results, and 6-methoxyapigenin and 6-methoxyluteolin were the most potent Cdk5 complex inhibitors within this series, while the common flavonols kaempferol and quercetin showed intermediate behavior. The reported crystal structure of the Cdk5 complex with its activator p25 was used for docking studies, which also led to the identification of the two 6-methoxyflavones, kaempferol and quercetin, as well as the untested 6-methoxy derivatives of kaempferol and quercetin and the corresponding 6-hydroxy analogues as compounds exhibiting a good fit to the active site of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043421     DOI: 10.1021/np034011s

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  9 in total

1.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.

Authors:  Angélica Maria Sabogal-Guáqueta; Juan Ignacio Muñoz-Manco; Jose R Ramírez-Pineda; Marisol Lamprea-Rodriguez; Edison Osorio; Gloria Patricia Cardona-Gómez
Journal:  Neuropharmacology       Date:  2015-02-07       Impact factor: 5.250

2.  Toward a unified therapeutics approach targeting putative amyloid-β oligomer receptors.

Authors:  Cassia R Overk; Eliezer Masliah
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-09       Impact factor: 11.205

3.  Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.

Authors:  Wolf Wrasidlo; Leslie A Crews; Igor F Tsigelny; Emily Stocking; Valentina L Kouznetsova; Diana Price; Amy Paulino; Tania Gonzales; Cassia R Overk; Christina Patrick; Edward Rockenstein; Eliezer Masliah
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

Review 4.  Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.

Authors:  Gerald Schmid; Joanna B Strosznajder; Józefa Wesierska-Gadek
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

Review 5.  Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.

Authors:  Johant Lakey-Beitia; Ruben Berrocal; K S Rao; Armando A Durant
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

6.  Identification and characterization of phosphorylation sites within the pregnane X receptor protein.

Authors:  Ayesha Elias; Anthony A High; Ashutosh Mishra; Su Sien Ong; Jing Wu; Junmin Peng; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2013-10-30       Impact factor: 5.858

7.  Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells.

Authors:  Hanqing Dong; Wenwei Lin; Jing Wu; Taosheng Chen
Journal:  BMC Biochem       Date:  2010-06-16       Impact factor: 4.059

8.  An insight into the potentially old-wonder molecule-quercetin: the perspectives in foresee.

Authors:  Nidhi Rani; Lakshmi Palanisamy Thanga Velan; Saravanan Vijaykumar; Annamalai Arunachalam
Journal:  Chin J Integr Med       Date:  2015-09-09       Impact factor: 1.978

9.  Myricetin Protects Against High Glucose-Induced β-Cell Apoptosis by Attenuating Endoplasmic Reticulum Stress via Inactivation of Cyclin-Dependent Kinase 5.

Authors:  Udayakumar Karunakaran; Suma Elumalai; Jun Sung Moon; Jae Han Jeon; Nam Doo Kim; Keun Gyu Park; Kyu Chang Won; Jaechan Leem; In Kyu Lee
Journal:  Diabetes Metab J       Date:  2019-01-16       Impact factor: 5.376

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.